Sale!

West Nile Virus RNA Detection Qualitative Test Cost

Original price was: 1,700 د.إ.Current price is: 1,450 د.إ.

-15%

The West Nile Virus RNA Detection Qualitative Test is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to accurately identify the presence of West Nile Virus (WNV) RNA in a patient’s blood sample. This test is particularly crucial for early detection and management of West Nile Virus infections, which are transmitted to humans through the bite of an infected mosquito. Utilizing advanced molecular techniques, this qualitative test determines the presence or absence of the virus, enabling healthcare providers to make informed decisions regarding patient care and treatment.

The cost of the test is set at 1450 AED, reflecting the advanced technology and expertise required to conduct this precise RNA detection. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is a critical resource for clinicians in the diagnosis and management of suspected West Nile Virus cases, ensuring timely intervention and care for affected individuals.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

West Nile Virus RNA Detection Qualitative Test

Cost: AED 1450.0

Test Name: West Nile Virus RNA Detection Qualitative Test

Components: Serum, plasma, whole blood, C.S.F

Report Delivery: 3rd Working Day (Email: 36 hours, On phone: 24 hours)

Method: Real Time PCR

Test Type: Viral

Doctor: Physician

Test Department: Genetics

Pre Test Information: Need to sign Consent document and bring any clinical history of patient for West Nile Virus (RNA Detection) Qualitative Test

Test Details

The West Nile Virus (RNA Detection) Qualitative Test is a diagnostic tool used to detect the presence of the West Nile Virus (WNV) RNA in a patient’s sample. This test is primarily used for early detection and confirmation of West Nile Virus infection.

The test relies on the detection of viral RNA, which is the genetic material of the virus. It uses a technique called reverse transcription-polymerase chain reaction (RT-PCR) to amplify and detect the specific RNA sequences of the West Nile Virus.

During the test, a small sample of blood or cerebrospinal fluid is collected from the patient. The RNA is then extracted from the sample and converted into complementary DNA (cDNA) using reverse transcription. The cDNA is then amplified using PCR, which creates millions of copies of the specific West Nile Virus RNA sequence if present in the sample.

To detect the amplified RNA, fluorescent probes or dyes specific to the West Nile Virus RNA are used. If the virus is present in the sample, the fluorescence will be detected, indicating a positive result for West Nile Virus infection. If there is no fluorescence, it means the virus is not present, and the result is negative.

The West Nile Virus (RNA Detection) Qualitative Test is highly sensitive and specific, providing accurate results for the diagnosis of West Nile Virus infection. It is commonly used in clinical laboratories and public health agencies to identify and monitor the spread of the virus.

It is important to note that this test only detects the presence of the West Nile Virus RNA and does not provide information about the severity of the infection or the patient’s immune response. Additional tests may be required to assess the patient’s condition and guide treatment decisions.

Test Name West Nile Virus RNA Detection Qualitative Test
Components
Price 1450.0 AED
Sample Condition Serum, plasma, whole blood C.S.F
Report Delivery 3rd Working Day Email:-36 hours.On phone: 24 hours
Method Real Time PCR
Test type Viral
Doctor Physician
Test Department: Genetics
Pre Test Information Need to sign Consent document and bring any clinical history of patient forWest Nile Virus (RNA Detection) QualitativeTest
Test Details

The West Nile Virus (RNA Detection) Qualitative Test is a diagnostic tool used to detect the presence of the West Nile Virus (WNV) RNA in a patient’s sample. This test is primarily used for early detection and confirmation of West Nile Virus infection.

The test relies on the detection of viral RNA, which is the genetic material of the virus. It uses a technique called reverse transcription-polymerase chain reaction (RT-PCR) to amplify and detect the specific RNA sequences of the West Nile Virus.

During the test, a small sample of blood or cerebrospinal fluid is collected from the patient. The RNA is then extracted from the sample and converted into complementary DNA (cDNA) using reverse transcription. The cDNA is then amplified using PCR, which creates millions of copies of the specific West Nile Virus RNA sequence if present in the sample.

To detect the amplified RNA, fluorescent probes or dyes specific to the West Nile Virus RNA are used. If the virus is present in the sample, the fluorescence will be detected, indicating a positive result for West Nile Virus infection. If there is no fluorescence, it means the virus is not present, and the result is negative.

The West Nile Virus (RNA Detection) Qualitative Test is highly sensitive and specific, providing accurate results for the diagnosis of West Nile Virus infection. It is commonly used in clinical laboratories and public health agencies to identify and monitor the spread of the virus.

It is important to note that this test only detects the presence of the West Nile Virus RNA and does not provide information about the severity of the infection or the patient’s immune response. Additional tests may be required to assess the patient’s condition and guide treatment decisions.